TGA grants provisional determination for COVID-19 vaccine
The TGA has granted a provisional determination to AstraZeneca Pty Ltd in relation to its COVID-19 Vaccine, ChAd0x1-S [recombinant].
Published
Related content
- TGA grants second provisional determination for a COVID-19 vaccineThe TGA has granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, BNT162b2 [mRNA]
- TGA grants third provisional determination for a COVID-19 vaccineOn 16 November 2020 the TGA granted a provisional determination to Janssen in relation to its COVID-19 vaccine, Ad26.COV2.S.
- TGA grants additional provisional determination for a COVID-19 vaccineThe TGA has granted a provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to the COVID-19 Vaccine, NVX-CoV2373.